About Babuline Pharma Private Limited
Data last updated:
Babuline Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 September 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1981PTC025180. Its GSTIN is 27AABCB4996Q1ZU (Maharashtra). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors including Bharat Navnitrai Oza (Managing Director) and Bhadresh Navnitrai Oza.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 406 Gulab Bldg. 237 P'Dmello Road, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.18 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net loss of ₹7.14 Lakh (net margin -2.2%) and EBITDA of -₹42,722 (EBITDA margin -0.1%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 8% over five years.
The company is associated with 1 brand: Babuline Pharma. As per MCA filings, the company has open charges of ₹22.46 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website babuline.com.
Company details
Contact details
Babuline Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is babuline.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address406 Gulab Bldg. 237 P'Dmello Road, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Babuline Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Babuline Pharma operates one associated brand: Babuline Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Baby care and pharmaceutical products manufacturing in India. | babuline.com |
Business activity
The main business activity of Babuline Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Babuline Pharma Private Limited, buy the company report.
Financials of Babuline Pharma Private Limited
FY 2025 filings availableBabuline Pharma Private Limited reported revenue of ₹3.18 Cr (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 13% fall in the latest year. EBITDA fell 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹42,722 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | ||||
| Net Profit Margin | -2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Babuline Pharma Private Limited, buy the company report.
Board of directors of Babuline Pharma Private Limited
Babuline Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharat Navnitrai Oza | Managing Director | 09 Sep 1981 | 45 Years 1 Months | Current |
| Bhadresh Navnitrai Oza Also directs: B A and Brothers(Bombay) Private Limited | Director | 09 Sep 1981 | 45 Years 1 Months | Current |
| Chanakya Bharat Oza | Director | 30 Sep 2008 | 18 Years 0 Months | Current |
| Kamlesh Prataprai Oza | Director | 31 Dec 1988 | 37 Years 9 Months | Current |
Peer comparison
Babuline Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rachil Remedies Pvt Ltd | ₹3.19 Cr (FY 2025) | -54.0% | Agra, Uttar Pradesh, India | |||
| Mepfarma India Private Limited | ₹3.18 Cr (FY 2025) | -6.0% | Chandigarh, India | |||
| Babuline Pharma Private Limitedthis company | ₹3.18 Cr (FY 2025) | -₹7.14 Lakh | -2.2% | -13.0% | Mumbai, Maharashtra, India | |
| Biostella Projects (OPC) Private Limited | ₹3.18 Cr (FY 2025) | 426.0% | Karimganj, Assam, India | |||
| Yuzderm Pharmaceuticals Private Limited | ₹3.17 Cr (FY 2025) | 61.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Babuline Pharma Private Limited, buy the company report.
Auditor
Babuline Pharma Private Limited is audited by KARIA & SHAH for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KARIA & SHAH | FY 2020 | 112203W |
Shareholding
The shareholding of Babuline Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Babuline Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jan 1998 | 90186530 | Mumbai Mercantile Co - Op. Bank Ltd. | ₹15 Lakh | Open | |
| 03 Jul 1990 | 90189091 | Mumbai Mercantile Co - Op. Bank Ltd. | ₹96,000 | Open | |
| 19 Jul 1986 | 90185092 | Mumbai Mercantile Co - Op. Bank Ltd. | ₹4 Lakh | Open | |
| 11 Mar 1985 | 90184944 | Mumbai Mercantile Co - Op. Bank Ltd. | ₹2.5 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
Babuline Pharma Private Limited has 2 court cases on record: 1 filed by Babuline Pharma, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (T.P. C) | Filed by the company against Maanav Herbal Ltd. | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Somnath Constructions Private Limited | Disposed |
To see the full case history of Babuline Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Babuline Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Babuline Pharma has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCB4996Q1ZU | Maharashtra | Active | 01 Jul 2017 |
| 24AABCB4996Q2ZZ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Babuline Pharma Private Limited, buy the company report.
Recent activity
Babuline Pharma Private Limited has 6 board changes on record since 1981: 4 appointments and 2 cessations. The latest: Chanakya Bharat Oza was appointed as Director on 30 Sep 2008.
1 earlier event is in the company report.
Frequently asked questions
Babuline Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 September 1981 (45+ years old) and is registered under CIN U24230MH1981PTC025180.
Babuline Pharma has 4 current directors:
- Bharat Navnitrai Oza - Managing Director
- Bhadresh Navnitrai Oza - Director
- Chanakya Bharat Oza - Director
- Kamlesh Prataprai Oza - Director
The latest financial statements of Babuline Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Babuline Pharma is 27AABCB4996Q1ZU, registered in Maharashtra. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 24AABCB4996Q2ZZ (Gujarat).
The CIN (Corporate Identification Number) of Babuline Pharma is U24230MH1981PTC025180. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Babuline Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.
Babuline Pharma was incorporated on 09 September 1981, making it 45+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Babuline Pharma by revenue are Rachil Remedies Pvt Ltd, Mepfarma India Private Limited, Biostella Projects (OPC) Private Limited, Yuzderm Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Chanakya Bharat Oza was appointed as Director on 30 Sep 2008. Navnitrai Bhavanishankar Oza ceased to be Director on 14 Mar 2008. Prataprai Bhavanishankar Oza ceased to be Director on 18 Dec 2007. Babuline Pharma has 6 board changes on record in total.
Babuline Pharma can be reached through the website babuline.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Babuline Pharma is at 406 Gulab Bldg. 237 PDmello Road, Mumbai, Maharashtra, India – 400001.